Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangshen Sanjie Fang (双参散结方) is a traditional Chinese medicine (TCM) formula. It is not a single chemical entity but rather a combination herbal preparation, typically used in TCM for its purported effects on tumor-related conditions and possibly other disorders involving nodules or masses. The name "Shuangshen" refers to the inclusion of two types of ginseng ("Ren Shen" and "Dang Shen"), while "Sanjie" suggests an action of dispersing or resolving masses/nodules. The precise composition may vary by manufacturer, but it generally contains multiple herbs with immunomodulatory, anti-inflammatory, and antitumor properties according to TCM theory. Mechanistically, such formulas are believed in TCM to regulate Qi and blood circulation, resolve phlegm/dampness, soften hardness (nodules), and support immune function; however, specific molecular targets are not well defined in Western pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuangshen Sanjie Fang.